Pfizer Requests Emergency Authorization For Five-Day COVID-19 Drug Regimen

The Washington Post (11/16, Johnson) reports Pfizer “requested emergency authorization Tuesday for its five-day antiviral” treatment “regimen, [PF-07321332] Paxlovid, making it the second easy-to-take treatment aimed at keeping newly infected people out o...